PedAM
Pediatric Disease Annotations & Medicines
| Disease | myocardial infarction |
| Phenotype | C0948265|metabolic syndrome |
| Sentences | 19 |
| PubMedID- 23411742 | Aim of this study was to determine the prevalence of metabolic syndrome in patients with premature myocardial infarction (before 50 years of age). |
| PubMedID- 20890426 | We sought to determine the prevalence of metabolic syndrome (ms) in patients with acute myocardial infarction and its effect on clinical outcomes. |
| PubMedID- 24020829 | Intra-thoracic fat volume is associated with myocardial infarction in patients with metabolic syndrome. |
| PubMedID- 23635324 | In the cardiovascular inflammation reduction trial (cirt) low dose methotrexate (target dose 20 mg/week) is tested for reduction of major cvd events among post-myocardial infarction patients with diabetes or metabolic syndrome[104]. |
| PubMedID- 22971940 | Presence of metabolic syndrome is associated with larger myocardial infarction size and complications following acute myocardial infarction. |
| PubMedID- 20811489 | Prevalence, detection, and management of the metabolic syndrome in patients with acute myocardial infarction: role of an obesity-centric definition. |
| PubMedID- 19356813 | Obesity and the metabolic syndrome in patients with acute myocardial infarction. |
| PubMedID- 25563711 | Effect of angiotensin converting enzyme inhibitors on periprocedural myocardial infarction in patients with metabolic syndrome. |
| PubMedID- 21428179 | The association between homocysteine level and metabolic syndrome in patients of prior myocardial infarction. |
| PubMedID- 21129152 | It also reduced the risk of myocardial infarction in patients with severe metabolic syndrome by 56% (8 year follow-up) and the development of type 2 diabetes by almost half (2 and 5 year follow-up) [26]. |
| PubMedID- 22240598 | Coronary artery bypass grafting for multivessel coronary artery disease in metabolic syndrome patients with acute myocardial infarction. |
| PubMedID- 20509277 | Aim: to analyze the components of metabolic syndrome from patients with cardiovascular disease (myocardial infarction). |
| PubMedID- 25789257 | However, very limited clinical data have addressed myocardial infarction size in patients with metabolic syndrome comparing to control subjects without metabolic syndrome. |
| PubMedID- 23715346 | The study was aimed to find out the impact of metabolic syndrome in patients with acute myocardial infarction during hospital stay. |
| PubMedID- 20488312 | metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries. |
| PubMedID- 22263382 | metabolic syndrome and outcome in patients with acute myocardial infarction. |
| PubMedID- 23934969 | Objective: this study aimed to evaluate long-term survival according to the presence of metabolic syndrome (ms) in patients with acute myocardial infarction (ami) undergoing successful percutaneous coronary intervention (pci) with drug-eluting stents (des). |
| PubMedID- 22701134 | The aim of this study was to evaluate clinical impact of non-hdl-c and apob on clinical outcomes in metabolic syndrome (ms) patients with acute myocardial infarction (ami) undergoing percuatneous coronary intervetion. |
| PubMedID- 21757819 | Background: the purpose of the present study was to compare the efficacy and safety of paclitaxel-eluting stent (pes), sirolimus-eluting stent (ses), and zotarolimus-eluting stent (zes) in primary percutaneous coronary intervention (pci) for acute st-segment elevation myocardial infarction (stemi) with metabolic syndrome (ms). |
Page: 1